Here is yet another day when an ARK Invest exchange-traded fund run by ETF star Cathie Wood parted with even more Pfizer Inc. (NYSE: PFE) shares. Specifically, the fund sold over 400,000 more shares, as the price of this ETF was flat in the day’s session. However, it is up in the past year.
[in-text-ad]
It was ARK Genomic Revolution ETF (NYSEARCA: ARKG) that shed 407,075 shares of Pfizer. At Thursday’s closing price, this would have valued this sale at roughly $20.4 million. This is only a small fraction of the total holdings. The fund is up about 1.5% over the past 52 weeks.
Check out all the ARK Invest sales for Thursday:
Fund | Ticker | Name | Shares |
---|---|---|---|
ARKG | VEEV | VEEVA SYSTEMS | 22,606 |
ARKG | REGN | REGENERON PHARMACEUTICALS | 15,885 |
ARKG | PFE | PFIZER | 407,075 |
ARKG | NSTG | NANOSTRING TECHNOLOGIES | 752 |
ARKG | IOVA | IOVANCE BIOTHERAPEUTICS | 70,800 |
ARKG | CLLS | CELLECTIS | 18,107 |
ARKG | CDXS | CODEXIS | 34,243 |
ARKK | Z | ZILLOW | 137,710 |
ARKK | U | UNITY SOFTWARE | 443,473 |
ARKK | PRLB | PROTO LABS | 29,096 |
ARKK | NSTG | NANOSTRING TECHNOLOGIES | 1,050 |
ARKK | COIN | COINBASE GLOBAL | 124,316 |
ARKW | COIN | COINBASE GLOBAL | 31,658 |
ARKW | PYPL | PAYPAL HOLDINGS | 100 |
ARKW | U | UNITY SOFTWARE | 57,398 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of a673b.bigscoots-temp.com.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.